KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.98

First bovine vaccine to prevent human schistosomiasis - a cluster randomised Phase 3 clinical trial.

Allen G Ross, Donald A Harn, Delia Chy, Marianette Inobaya, Jerric R Guevarra, Lisa Shollenberger, Yuesheng Li, Donald P McManus, Darren J Gray, Gail M Williams

Int J Infect Dis 129 110-117

PMID36736992
PMCID-
DOI10.1016/j.ijid.2023.01.037
发表日期2023-02-03
入排依据:未发现恶性肿瘤人群证据。
摘要

摘要

OBJECTIVE: Schistosomiasis is a neglected tropical parasitic disease caused by blood flukes of the genus Schistosoma. Schistosoma japonicum is zoonotic in China, the Philippines, and Indonesia, with bovines acting as major reservoirs of human infection. The primary objective of the trial was to examine the impact of a combination of human mass chemotherapy, snail control through mollusciciding, and SjCTPI bovine vaccination on the rate of human infection. METHODS: A 5-year phase IIIa cluster randomized control trial was conducted among 18 schistosomiasis-endemic villages comprising 18,221 residents in Northern Samar, The Philippines. RESULTS: Overall, bovine vaccination resulted in a statistically significant decrease in human infection (relative risk [RR] = 0.75; 95% confidence interval [CI] = 0.69 to 0.82) across all trial follow-ups. The best outcome of the trial was when bovine vaccination was combined with snail mollusciciding. This combination resulted in a 31% reduction (RR = 0.69; 95% CI = 0.61 to 0.78) in human infection. CONCLUSION: This is the first trial to demonstrate the effectiveness of a bovine vaccine for schistosomiasis in reducing human schistosome infection. The trial is registered with Australian New Zealand Clinical Trials Registry (ACTRN12619001048178).

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。